PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.

Figure 2 reports the analysis of the three endpoints of interest over time, clearly revealing an increasing trend of ICIs administration within 30 days and ICIs initiation within 30 days/3 months of death, over the years.

also in 63,971 other papers